Artelo Biosciences, Inc. (NASDAQ:ARTL) Financings

Artelo Biosciences, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Closed: US$2M raised · US$4.4 a share · R.F. Lafferty & Co., Inc.
Dealers: R.F. Lafferty & Co., Inc. (lead)
Oct 1, 2025
Public offering of shares of common stock and pre-funded warrants
Closed: US$3M raised · US$4.4 a share · R. F. Lafferty & Co., Inc.
Dealers: R. F. Lafferty & Co., Inc. (lead)
Sep 5, 2025
Private placement of shares of common stock (or pre-funded warrants) and warrants
Announced: about US$9.47M · US$10.45 a share · three-year warrants to purchase 906,687 shares at $10.20 per share and three-year… · R. F. Lafferty & Co., Inc.
Dealers: R. F. Lafferty & Co., Inc.
Buyers: Bartosz Lipiński (lead investor)
Use of proceeds: Launch a Solana (SOL)-centric digital asset treasury strategy and support ongoing business
Aug 4, 2025
Private placement of shares of common stock, pre-funded warrants and accompanying warrants
Announced: about US$1.43M · accompanying warrants to purchase 460,046 shares at $5.82 per share and 230,023 shares…
Use of proceeds: Announce clinical data for ART26.12 and ART27.13 studies; $250,000 to buy SOL digital currency; balance for general corporate and working capital
Jun 26, 2025
At-market convertible notes
Closed: US$900,000 raised
Use of proceeds: To fund company operations until additional financing is completed
May 13, 2025

Read by 6ix AI from the company's releases